Concepts (186)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Endoscopy | 14 | 2024 | 350 | 3.740 |
Why?
|
Skull Base | 11 | 2022 | 48 | 3.430 |
Why?
|
Rhinitis | 6 | 2023 | 179 | 2.980 |
Why?
|
Sinusitis | 5 | 2024 | 215 | 2.410 |
Why?
|
Rhinitis, Allergic | 3 | 2023 | 45 | 2.020 |
Why?
|
Otorhinolaryngologic Surgical Procedures | 3 | 2017 | 16 | 1.660 |
Why?
|
Neurosurgical Procedures | 4 | 2021 | 232 | 1.620 |
Why?
|
Pituitary Neoplasms | 2 | 2024 | 69 | 1.460 |
Why?
|
Frontal Sinus | 2 | 2022 | 7 | 1.440 |
Why?
|
Otolaryngology | 2 | 2022 | 55 | 1.400 |
Why?
|
Nasal Septum | 3 | 2018 | 28 | 1.330 |
Why?
|
Adenoma | 2 | 2024 | 246 | 1.300 |
Why?
|
Paranasal Sinuses | 4 | 2018 | 60 | 1.290 |
Why?
|
Cerebrospinal Fluid Leak | 2 | 2017 | 10 | 1.160 |
Why?
|
Turbinates | 3 | 2022 | 11 | 1.150 |
Why?
|
Sella Turcica | 2 | 2017 | 17 | 1.150 |
Why?
|
Office Visits | 2 | 2024 | 50 | 1.090 |
Why?
|
Video Recording | 2 | 2024 | 203 | 1.060 |
Why?
|
Skull Base Neoplasms | 2 | 2016 | 13 | 1.060 |
Why?
|
Social Media | 2 | 2024 | 95 | 1.000 |
Why?
|
Postoperative Complications | 8 | 2022 | 2284 | 0.990 |
Why?
|
Olfaction Disorders | 2 | 2022 | 68 | 0.930 |
Why?
|
Angiofibroma | 1 | 2023 | 4 | 0.870 |
Why?
|
Eustachian Tube | 1 | 2023 | 9 | 0.870 |
Why?
|
Patient Satisfaction | 3 | 2022 | 461 | 0.860 |
Why?
|
Ear Diseases | 1 | 2023 | 20 | 0.850 |
Why?
|
Nasopharyngeal Neoplasms | 1 | 2023 | 47 | 0.840 |
Why?
|
Olfactory Cortex | 1 | 2022 | 5 | 0.830 |
Why?
|
Encephalocele | 1 | 2022 | 26 | 0.790 |
Why?
|
Nasal Surgical Procedures | 3 | 2018 | 8 | 0.790 |
Why?
|
Ambulatory Care Facilities | 1 | 2022 | 111 | 0.770 |
Why?
|
Hypersensitivity | 1 | 2023 | 158 | 0.770 |
Why?
|
Nasal Cavity | 2 | 2018 | 91 | 0.700 |
Why?
|
Rhinoplasty | 3 | 2018 | 35 | 0.700 |
Why?
|
Humans | 43 | 2024 | 89356 | 0.700 |
Why?
|
Embolization, Therapeutic | 1 | 2023 | 262 | 0.690 |
Why?
|
Surgery, Computer-Assisted | 2 | 2017 | 98 | 0.660 |
Why?
|
Nasal Lavage | 1 | 2018 | 2 | 0.630 |
Why?
|
Telemedicine | 1 | 2021 | 188 | 0.630 |
Why?
|
Surgical Flaps | 2 | 2019 | 249 | 0.610 |
Why?
|
Diet | 1 | 2021 | 442 | 0.610 |
Why?
|
Sublingual Immunotherapy | 1 | 2017 | 2 | 0.600 |
Why?
|
Withholding Treatment | 1 | 2018 | 117 | 0.600 |
Why?
|
Nutrition Surveys | 4 | 2023 | 111 | 0.590 |
Why?
|
Desensitization, Immunologic | 1 | 2017 | 37 | 0.580 |
Why?
|
Invasive Pulmonary Aspergillosis | 1 | 2017 | 8 | 0.580 |
Why?
|
Sleep Wake Disorders | 1 | 2018 | 117 | 0.570 |
Why?
|
Orbit | 1 | 2017 | 38 | 0.560 |
Why?
|
Cricoid Cartilage | 1 | 2016 | 4 | 0.550 |
Why?
|
Patient Safety | 2 | 2016 | 218 | 0.550 |
Why?
|
Laryngoplasty | 1 | 2016 | 5 | 0.550 |
Why?
|
Allergens | 1 | 2017 | 183 | 0.550 |
Why?
|
Esthesioneuroblastoma, Olfactory | 1 | 2016 | 2 | 0.540 |
Why?
|
Neurosurgery | 1 | 2017 | 100 | 0.530 |
Why?
|
Paranasal Sinus Neoplasms | 1 | 2016 | 25 | 0.520 |
Why?
|
Cross-Sectional Studies | 5 | 2023 | 1714 | 0.520 |
Why?
|
Quality Improvement | 3 | 2018 | 451 | 0.500 |
Why?
|
Tracheotomy | 1 | 2015 | 18 | 0.500 |
Why?
|
Otologic Surgical Procedures | 1 | 2015 | 13 | 0.500 |
Why?
|
Trachea | 1 | 2016 | 291 | 0.500 |
Why?
|
Laryngostenosis | 1 | 2015 | 18 | 0.490 |
Why?
|
Intraoperative Complications | 1 | 2016 | 188 | 0.490 |
Why?
|
Tracheal Stenosis | 1 | 2015 | 25 | 0.490 |
Why?
|
Nose | 5 | 2022 | 94 | 0.490 |
Why?
|
Depression | 1 | 2019 | 505 | 0.490 |
Why?
|
Retrospective Studies | 11 | 2024 | 9057 | 0.470 |
Why?
|
Nasal Obstruction | 3 | 2018 | 21 | 0.450 |
Why?
|
Male | 19 | 2024 | 42411 | 0.420 |
Why?
|
Child, Preschool | 6 | 2024 | 3731 | 0.420 |
Why?
|
Child | 7 | 2024 | 7174 | 0.410 |
Why?
|
Young Adult | 7 | 2023 | 6312 | 0.410 |
Why?
|
Facial Asymmetry | 1 | 2012 | 12 | 0.410 |
Why?
|
Adult | 11 | 2024 | 26607 | 0.400 |
Why?
|
Facial Expression | 1 | 2012 | 51 | 0.390 |
Why?
|
Body Image | 1 | 2012 | 78 | 0.390 |
Why?
|
United States | 6 | 2024 | 6989 | 0.380 |
Why?
|
Adolescent | 7 | 2023 | 9263 | 0.370 |
Why?
|
Aged | 9 | 2024 | 19165 | 0.370 |
Why?
|
Female | 17 | 2024 | 46202 | 0.370 |
Why?
|
Reoperation | 3 | 2018 | 599 | 0.360 |
Why?
|
Middle Aged | 10 | 2024 | 25974 | 0.340 |
Why?
|
Asthma | 1 | 2017 | 978 | 0.330 |
Why?
|
Patient Readmission | 3 | 2018 | 352 | 0.330 |
Why?
|
Postoperative Period | 2 | 2022 | 302 | 0.320 |
Why?
|
Magnetic Resonance Imaging | 5 | 2022 | 3448 | 0.300 |
Why?
|
Tomography, X-Ray Computed | 5 | 2021 | 2661 | 0.270 |
Why?
|
Minimally Invasive Surgical Procedures | 2 | 2018 | 253 | 0.250 |
Why?
|
Otitis Media | 1 | 2024 | 20 | 0.240 |
Why?
|
Current Procedural Terminology | 1 | 2024 | 12 | 0.240 |
Why?
|
Databases, Factual | 3 | 2018 | 856 | 0.230 |
Why?
|
Smell | 2 | 2022 | 111 | 0.230 |
Why?
|
Anti-Bacterial Agents | 2 | 2021 | 788 | 0.230 |
Why?
|
Patient Education as Topic | 2 | 2024 | 360 | 0.230 |
Why?
|
Treatment Outcome | 5 | 2021 | 8241 | 0.220 |
Why?
|
Neoplasm Recurrence, Local | 2 | 2023 | 1365 | 0.220 |
Why?
|
Aged, 80 and over | 3 | 2019 | 6811 | 0.220 |
Why?
|
Gray Matter | 1 | 2022 | 35 | 0.200 |
Why?
|
Olfactory Bulb | 1 | 2022 | 40 | 0.200 |
Why?
|
Facial Pain | 1 | 2021 | 11 | 0.200 |
Why?
|
Adenoidectomy | 1 | 2021 | 23 | 0.190 |
Why?
|
Cadaver | 2 | 2020 | 185 | 0.190 |
Why?
|
Bayes Theorem | 1 | 2023 | 370 | 0.190 |
Why?
|
Infant, Newborn | 2 | 2017 | 2485 | 0.180 |
Why?
|
Chronic Disease | 2 | 2021 | 950 | 0.180 |
Why?
|
Neuroimaging | 1 | 2021 | 117 | 0.180 |
Why?
|
Surveys and Questionnaires | 3 | 2024 | 2624 | 0.170 |
Why?
|
Acute Disease | 2 | 2024 | 841 | 0.170 |
Why?
|
Infant | 2 | 2017 | 3160 | 0.170 |
Why?
|
Frailty | 1 | 2020 | 76 | 0.160 |
Why?
|
Cognitive Dysfunction | 1 | 2021 | 146 | 0.160 |
Why?
|
Drug-Eluting Stents | 1 | 2018 | 16 | 0.160 |
Why?
|
Prognosis | 2 | 2017 | 3783 | 0.160 |
Why?
|
Absorbable Implants | 1 | 2018 | 35 | 0.160 |
Why?
|
Immunoglobulin E | 1 | 2019 | 145 | 0.160 |
Why?
|
Fluorescein | 1 | 2018 | 16 | 0.160 |
Why?
|
Odontoid Process | 1 | 2018 | 3 | 0.160 |
Why?
|
Nasopharynx | 1 | 2018 | 50 | 0.150 |
Why?
|
Prevalence | 2 | 2020 | 1243 | 0.150 |
Why?
|
Autografts | 1 | 2017 | 28 | 0.150 |
Why?
|
Administration, Cutaneous | 1 | 2017 | 60 | 0.150 |
Why?
|
Mucous Membrane | 1 | 2017 | 83 | 0.150 |
Why?
|
Health Surveys | 1 | 2018 | 240 | 0.150 |
Why?
|
Operating Rooms | 1 | 2018 | 129 | 0.150 |
Why?
|
North America | 1 | 2017 | 184 | 0.150 |
Why?
|
Elective Surgical Procedures | 1 | 2018 | 126 | 0.150 |
Why?
|
Follow-Up Studies | 2 | 2016 | 3666 | 0.140 |
Why?
|
Odds Ratio | 1 | 2019 | 683 | 0.140 |
Why?
|
Safety | 1 | 2017 | 149 | 0.140 |
Why?
|
Cystic Fibrosis Transmembrane Conductance Regulator | 1 | 2017 | 56 | 0.140 |
Why?
|
Allografts | 1 | 2017 | 181 | 0.140 |
Why?
|
Skin Transplantation | 1 | 2017 | 184 | 0.130 |
Why?
|
Transplants | 1 | 2016 | 41 | 0.130 |
Why?
|
Immunocompromised Host | 1 | 2017 | 142 | 0.130 |
Why?
|
Academic Medical Centers | 1 | 2018 | 385 | 0.130 |
Why?
|
Patient Acceptance of Health Care | 1 | 2018 | 260 | 0.130 |
Why?
|
Cystic Fibrosis | 1 | 2017 | 115 | 0.130 |
Why?
|
Perioperative Care | 1 | 2017 | 170 | 0.130 |
Why?
|
Treatment Failure | 1 | 2016 | 287 | 0.130 |
Why?
|
Infant, Premature, Diseases | 1 | 2016 | 77 | 0.130 |
Why?
|
Mastoid | 1 | 2015 | 17 | 0.120 |
Why?
|
Hemorrhage | 1 | 2017 | 280 | 0.120 |
Why?
|
Cochlear Implantation | 1 | 2015 | 33 | 0.120 |
Why?
|
Time Factors | 1 | 2024 | 5338 | 0.120 |
Why?
|
Laryngoscopy | 1 | 2015 | 47 | 0.120 |
Why?
|
Societies, Medical | 1 | 2017 | 575 | 0.110 |
Why?
|
Randomized Controlled Trials as Topic | 1 | 2017 | 838 | 0.110 |
Why?
|
Survival Analysis | 1 | 2017 | 1534 | 0.110 |
Why?
|
Imaging, Three-Dimensional | 1 | 2017 | 598 | 0.100 |
Why?
|
Sleep Apnea, Obstructive | 1 | 2015 | 216 | 0.100 |
Why?
|
Beauty | 1 | 2012 | 8 | 0.100 |
Why?
|
Photography | 1 | 2012 | 37 | 0.100 |
Why?
|
Risk Factors | 3 | 2018 | 5499 | 0.100 |
Why?
|
Intensive Care Units | 1 | 2015 | 396 | 0.100 |
Why?
|
Hemangioblasts | 1 | 2010 | 1 | 0.090 |
Why?
|
Pluripotent Stem Cells | 1 | 2010 | 33 | 0.090 |
Why?
|
Hepatitis C, Chronic | 1 | 2009 | 91 | 0.080 |
Why?
|
Hematopoietic Stem Cells | 1 | 2010 | 299 | 0.070 |
Why?
|
Kidney Diseases | 1 | 2009 | 319 | 0.070 |
Why?
|
Biopsy | 1 | 2009 | 1184 | 0.060 |
Why?
|
Nose Diseases | 1 | 2024 | 11 | 0.060 |
Why?
|
Cell Differentiation | 1 | 2010 | 1525 | 0.050 |
Why?
|
Taste Disorders | 1 | 2020 | 8 | 0.050 |
Why?
|
Logistic Models | 2 | 2018 | 1213 | 0.050 |
Why?
|
Sphenoid Sinus | 1 | 2020 | 7 | 0.050 |
Why?
|
HIV Infections | 1 | 2009 | 840 | 0.050 |
Why?
|
Evidence-Based Practice | 1 | 2019 | 48 | 0.040 |
Why?
|
Dementia | 1 | 2021 | 194 | 0.040 |
Why?
|
Cervical Vertebrae | 1 | 2018 | 83 | 0.040 |
Why?
|
Adrenal Cortex Hormones | 1 | 2018 | 266 | 0.040 |
Why?
|
Respiratory Function Tests | 1 | 2017 | 139 | 0.030 |
Why?
|
Multivariate Analysis | 1 | 2018 | 988 | 0.030 |
Why?
|
Sex Factors | 1 | 2018 | 1066 | 0.030 |
Why?
|
Polysomnography | 1 | 2015 | 151 | 0.030 |
Why?
|
Age Factors | 1 | 2018 | 1870 | 0.030 |
Why?
|
Genotype | 1 | 2017 | 1849 | 0.030 |
Why?
|
Brain | 1 | 2021 | 2285 | 0.020 |
Why?
|
Hematuria | 1 | 2009 | 50 | 0.020 |
Why?
|
Cell Culture Techniques | 1 | 2010 | 192 | 0.020 |
Why?
|
Hematoma | 1 | 2009 | 108 | 0.020 |
Why?
|
Ultrasonography | 1 | 2009 | 712 | 0.020 |
Why?
|
Quality of Life | 1 | 2015 | 1668 | 0.020 |
Why?
|
Case-Control Studies | 1 | 2009 | 1862 | 0.020 |
Why?
|
Predictive Value of Tests | 1 | 2009 | 1723 | 0.020 |
Why?
|
Hematopoietic Stem Cell Transplantation | 1 | 2010 | 890 | 0.010 |
Why?
|
Models, Biological | 1 | 2010 | 1765 | 0.010 |
Why?
|
Animals | 1 | 2010 | 27369 | 0.010 |
Why?
|